Atara Biotherapeutics to Receive Additional Near-Term Milest

Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre

Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California , United States , South San Francisco , Pierre Fabre , Eric Hyllengren , Alex Chapman , Eric Ducournau , Pascal Touchon , Atara Biotherapeutics Inc , Linkedin , Twitter , European Commission , Drug Administration , Nasdaq , Exchange Commission , European Medicines Agency , Securities Exchange , Million Upon European Commission Ec Approval , Receive Additional , Upon European Commission , Marketing Authorization Transfer , Final Day , Marketing Authorization Application , Middle East , Breakthrough Therapy Designation , Priority Medicines , Securities Act , Securities Exchange Act , Southern California , Financial Condition ,